Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) Stock Price Down 58.3% – Time to Sell?

Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF) shares fell 58.3% on Wednesday . The stock traded as low as $3.16 and last traded at $3.5775. 78,120 shares were traded during trading, an increase of 2,059% from the average session volume of 3,619 shares. The stock had previously closed at $8.58.

Wall Street Analysts Forecast Growth

Separately, Pareto Securities cut shares of Surgical Science Sweden AB (publ) to a “hold” rating in a report on Wednesday. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, the company has a consensus rating of “Hold”.

Surgical Science Sweden AB (publ) Stock Performance

The stock has a 50 day simple moving average of $8.95 and a 200-day simple moving average of $11.94.

About Surgical Science Sweden AB (publ)

Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.